RFX6 is needed for the development and maintenance of the β-cell phenotype

Islets

Volumn 3, Issue 5, 2011, Pages 291-293

  Taleb, Nadine ^a   Polychronakos, Constantin ^a  

^a MCGILL UNIVERSITY   (Canada)

Author keywords

cell replacement; Diabetes mellitus; Endocrine pancreas development; Homozygosity mapping; RFX6

Indexed keywords

INTERFERON REGULATORY FACTOR 6;

ARTICLE; CELL MATURATION; DIABETES MELLITUS; GENE MAPPING; HOMOZYGOSITY; MEDICAL RESEARCH; MOUSE; MUTATION; NONHUMAN; PANCREAS ISLET; PANCREAS ISLET BETA CELL; PHENOTYPE;

ANIMALS; DIABETES MELLITUS; DNA-BINDING PROTEINS; GENE EXPRESSION REGULATION, DEVELOPMENTAL; HOMOZYGOTE; HUMANS; INSULIN-SECRETING CELLS; ISLETS OF LANGERHANS; MICE; PHENOTYPE; TRANSCRIPTION FACTORS;

EID: 80052782507     PISSN: 19382014     EISSN: 19382022     Source Type: Journal    
DOI: 10.4161/isl.3.5.15944     Document Type: Article

References (22)

1. Smith SB, Qu HQ, Taleb N, Kishimoto NY, Scheel DW, Lu Y, et al. Rfx6 directs islet formation and insulin production in mice and humans. Nature 2010; 463:775-80.
2. Aftab S, Semenec L, Chu JS, Chen N. Identification and characterization of novel human tissue-specific RFX transcription factors. BMC Evol Biol 2008; 8:226.
3. Feng C, Xu W, Zuo Z. Knockout of the regulatory factor X1 gene leads to early embryonic lethality. Biochem Biophys Res Commun 2009; 386:715-7.
4. Ait-Lounis A, Baas D, Barras E, Benadiba C, Charollais A, Nlend Nlend R, et al. Novel function of the ciliogenic transcription factor RFX3 in development of the endocrine pancreas. Diabetes 2007; 56:950-9. (Pubitemid 46525062)
5. Rhodes DR, Tomlins SA, Varambally S, Mahavisno V, Barrette T, Kalyana-Sundaram S, et al. Probabilistic model of the human protein-protein interaction network. Nat Biotechnol 2005; 23:951-9. (Pubitemid 41114028)
6. Mitchell J, Punthakee Z, Lo B, Bernard C, Chong K, Newman C, et al. Neonatal diabetes, with hypoplastic pancreas, intestinal atresia and gall bladder hypoplasia: search for the aetiology of a new autosomal recessive syndrome. Diabetologia 2004; 47:2160-7. (Pubitemid 40174689)
7. Pearl EJ, Jarikji Z, Horb ME. Functional analysis of Rfx6 and mutant variants associated with neonatal diabetes. Dev Biol 2011; 351:135-45.
8. Miyatsuka T, Li Z, German MS. Chronology of islet differentiation revealed by temporal cell labeling. Diabetes 2009; 58:1863-8.
9. Gradwohl G, Dierich A, LeMeur M, Guillemot F. Neurogenin3 is required for the development of the four endocrine cell lineages of the pancreas. Proc Natl Acad Sci USA 2000; 97:1607-11. (Pubitemid 30118489)
10. Wang S, Hecksher-Sorensen J, Xu Y, Zhao A, Dor Y, Rosenberg L, et al. Myt1 and Ngn3 form a feed-forward expression loop to promote endocrine islet cell differentiation. Dev Biol 2008; 317:531-40.
11. Wang J, Cortina G, Wu SV, Tran R, Cho JH, Tsai MJ, et al. Mutant neurogenin-3 in congenital malabsorptive diarrhea. N Eng J Med 2006; 355:270-80. (Pubitemid 44079341)
12. Cras-Méneur C, Li L, Kopan R, Permutt MA. Notch dose control the fate of pancreatic endocrine progenitors during a narrow developmental window. Genes Dev 2009; 23:2088-101.
13. Martinovici D, Ransy V, Vanden Eijnden S, Ridremont C, Pardou A, Cassart M, et al. Neonatal hemochromatosis and Martinez-Frias syndrome of intestinal atresia and diabetes mellitus in a consanguineous newborn. Eur J Med Genet 2010; 53:25-8.
14. Nakayama A, Murakami H, Maeyama N, Yamashiro N, Sakakibara A, Mori N, et al. Role for RFX transcription factors in non-neuronal cell-specific inactivation of the microtubule-associated protein MAP1A promoter. J Biol Chem 2003; 278:233-40. (Pubitemid 36043567)
15. Iwama A, Pan J, Zhang P, Reith W, Mach B, Tenen DG, et al. Dimeric RFX proteins contribute to the activity and lineage specificity of the interleukin-5 receptor alpha promoter through activation and repression domains. Mol Cell Biol 1999; 19:3940-50. (Pubitemid 29241968)
16. Aguayo-Mazzucato C, Bonner-Weir S. Stem cell therapy for type 1 diabetes mellitus. Nat Rev Endocrinol 2010; 6:139-48.
17. Halban PA, German MS, Kahn SE, Weir GC. Current status of islet cell replacement and regeneration therapy. J Clin Endocrinol Metab 2010; 95:1034-43.
18. Pechhold K, Koczwara K, Zhu X, Harrison VS, Walker G, Lee J, et al. Blood glucose levels regulate pancreatic beta-cell proliferation during experimentally-induced and spontaneous autoimmune diabetes in mice. PLoS One 2009; 4:4827.
19. Inada A, Nienaber C, Katsuta H, Fujitani Y, Levine J, Morita R, et al. Carbonic anhydrase II-positive pancreatic cells are progenitors for both endocrine and exocrine pancreas after birth. Proc Natl Acad Sci USA 2008; 105:19915-9.
20. Bonner-Weir S, Inada A, Yatoh S, Li WC, Aye T, Toschi E, et al. Transdifferentiation of pancreatic ductal cells to endocrine beta-cells. Biochem Soc Trans 2008; 36:353-6. (Pubitemid 351839330)
21. Zhou Q, Brown J, Kanarek A, Rajagopal J, Melton DA. In vivo reprogramming of adult pancreatic exocrine cells to beta-cells. Nature 2008; 455:627-32.
22. Karaca M, Castel J, Tourrel-Cuzin C, Brun M, Géant A, Dubois M, et al. Exploring functional beta-cell heterogeneity in vivo using PSA-NCAM as a specific marker. Plos One 2009; 4:5555.